Skip to main content
. 2017 May 17;12(5):e0177824. doi: 10.1371/journal.pone.0177824

Fig 1. Pluripotent characterization of reprogrammed AFSC-iPSC.

Fig 1

(A) Immunostaining for the human pluripotency markers OCT4, NANOG, TRA-1-60, and TRA-1-81. Scale bars, 100μm. (B) AFSC-iPSC-derived teratoma exhibiting neural epithelium (ectoderm, right) and gut epithelium (endoderm, bottom) surrounded by muscle and adipose tissue (mesoderm, top left) Scale bar, 100μm.